List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 130 studies with search of:   Slovenia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Condition: Asthma
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Fluticasone propionate and salmeterol (F/SC) DPI
2 Recruiting Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
Condition: Hypertension
Interventions: Drug: telmisartan;   Drug: telmisartan + hydrochlorothiazide
3 Recruiting Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice
Condition: Asthma
Intervention:
4 Completed STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
Condition: Asthma
Intervention: Drug: Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy
5 Completed MICHELANGELO OASIS-6 : FOndaparinux in ST Elevation Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: fondaparinux sodium;   Drug: heparin;   Drug: Glucose-insulin-potassium (GIK)
6 Completed Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: tiotropium
7 Recruiting Varenicline Observational Investigation In The Cessation of Smoking
Condition: Smoking Cessation
Intervention: Drug: Varenicline
8 Recruiting Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium bromide;   Drug: Salmeterol
9 Active, not recruiting "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Prostate Cancer
Intervention: Drug: Dutasteride
10 Recruiting A Double-Blind, Placebo-Controlled, 2-Year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease.
Conditions: Dementia, Alzheimer Type;   Alzheimer Disease
Interventions: Drug: Galantamine;   Drug: Placebo
11 Recruiting Placebo Controlled, Randomized, Double-Blind, Multi-Center Study to Investigate the Efficacy and Tolerability of BAY 58-2667
Condition: Congestive Heart Failure
Interventions: Drug: Placebo;   Drug: BAY 58-2667
12 Completed SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Tiotropium bromide 18mcg;   Drug: Fluticasone propionate/ salmeterol combination 50/500mcg
13 Terminated GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults
Condition: Sepsis
Intervention: Drug: Intravenous GR270773- Phospholipid Emulsion
14 Completed Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.
Conditions: Hypertension;   Hyperlipidemia
Intervention: Drug: Amlodipine/atorvastatin single pill
15 Active, not recruiting A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: erlotinib [Tarceva];   Drug: Placebo
16 Active, not recruiting Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
Conditions: Prostate Cancer;   Pancreatic Cancer;   Non-Small-Cell Lung Cancer
Intervention: Drug: Nadroparin
17 Recruiting Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate MDI (MF MDI);   Drug: Formoterol MDI;   Drug: Placebo
18 Recruiting A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: erlotinib [Tarceva];   Drug: Alimta or Taxotere
19 Active, not recruiting A Phase III A Study to Assess the Safety of CDP870 for up to 30 Months Exposure
Condition: Crohn's Disease
Intervention: Biological: CDP870
20 Recruiting Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate/formoterol (MF/F) combination;   Drug: Mometasone furoate MDI (MF MDI);   Drug: Formoterol MDI;   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services